Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026)
Tango Therapeutics' (TNGX) quarterly Tax Provisions came in at $1000.0 in Q1 2026, down 97.06% year-on-year from $34000.0 in Q1 2025, and up 101.79% quarter-over-quarter from -$56000.0 in Q4 2025.
Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026) Analysis & Trends
Tango Therapeutics' Tax Provisions history runs 7 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 97.06% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was -$30000.0, a 114.85% decrease from a year earlier, with the FY2025 full-year figure at $3000.0, down 98.56% from the prior year.
- Tax Provisions climbed to $1000.0 in Q1 2026 per TNGX's latest filing, from -$56000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $100000.0 in Q2 2023 and bottomed at -$56000.0 in Q4 2025.
- The 5-year median for Tax Provisions is $34500.0 (2025), against an average of $32000.0.
- Across the five-year window, Tax Provisions surged 3233.33% in 2023 and tumbled 214.29% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $97000.0 in 2022, then tumbled by 86.6% to $13000.0 in 2023, then jumped by 276.92% to $49000.0 in 2024, then tumbled by 214.29% to -$56000.0 in 2025, then soared by 101.79% to $1000.0 in 2026.
- Per Business Quant, the three latest TNGX Tax Provisions figures stand at $1000.0 (Q1 2026), -$56000.0 (Q4 2025), and -$10000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tango Therapeutics | 3.82 Bn | 3.66 Bn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -56,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 177,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | 74,000.00 |
| Dec 31, 2020 | 6,864.00 |